Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Elena Anatolievna KatuninaFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0001-5805-486X
Mikhail Yurievich MartynovFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0003-2797-7877
Vsevolod Vadimovich BelousovFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0001-6637-8098
Nataliya Vladimirovna TitovaFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0002-7044-3013
Mikhail Borisovich DolgushinFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0003-3930-5998
Raisa Tairovna TairovaFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0002-4174-7114
Natalia Nikolaevna ShipilovaFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0002-7151-6544
Madina Zamirovna IvanovaFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0002-1393-0413
Ilya Vladimirovich SenkoFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0002-5743-8279
Ivan Sergeevich GuminFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0003-2360-3261
Vijay Mais-Ogly DzhafarovFederal Center of Brain Research and Neurotechnologies, Russian Federal Medical and Biological Agency, Ostrovityanova Str., 1, Building 10, 117513 Moscow, Russia.ORCID 0000-0002-5337-8715
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
activities of daily living (ADL)anxietydementiadepressionFUS thalamotomymagnetic resonance guided focused ultrasound (MRgFUS)mild cognitive impairment (MCI)Parkinson’s diseasequality of life (QoL)tremor
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
The Results of a 12-Month Open-Label Follow-Up Study with MRI Monitoring of Patients with Parkinson's Disease After MRI-Guided FUS. · full record | Socratic